Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2026)

Takeda Pharmaceutical has reported Change in Inventory for 9 years, with the latest figure at -$209.6 million in Q2 2026.

• On a quarterly basis, Change in Inventory fell 132.04% year-over-year to -$209.6 million in Q2 2026; TTM through Jun 2026 was -$533.6 million, a 105.89% decrease from a year earlier, with the FY2026 full-year figure at -$390.8 million, down 70.23% from the prior year.
• Change in Inventory was -$209.6 million for Q2 2026 at Takeda Pharmaceutical, down from $119.2 million in the prior quarter.
• The five-year high for Change in Inventory was $139.7 million in Q4 2024, with the low at -$342.0 million in Q4 2023.
• Average Change in Inventory over 5 years is -$128.4 million, with a median of -$110.5 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory sank 608.63% in 2023, then jumped 464.42% in 2026.
• Over 5 years, Change in Inventory stood at -$130.7 million in 2022, then sank by 161.71% to -$342.0 million in 2023, then surged by 140.85% to $139.7 million in 2024, then slumped by 276.58% to -$246.7 million in 2025, then gained by 15.04% to -$209.6 million in 2026.
• The last three Change in Inventory figures came in at -$209.6 million (Q2 2026), $119.2 million (Q1 2026), and -$246.7 million (Q4 2025), per Business Quant data.